https://openbell.ai/ 2026-10-08T16:52:55.239Z hourly 1.0 https://openbell.ai/support 2026-10-08T16:52:55.239Z monthly 0.7 https://openbell.ai/privacy 2026-10-08T16:52:55.239Z monthly 0.5 https://openbell.ai/terms 2026-10-08T16:52:55.239Z monthly 0.5 https://openbell.ai/feed.json 2026-10-08T16:52:55.239Z hourly 0.8 https://openbell.ai/news/MSFT:1791478228899 2026-10-08T16:50:28.899Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'OpenAI annualised revenues $20bn less than previously signalled' - Financial Times OpenAI's annualized revenues are now reported to be $20 billion less than previously indicated. This adjustment may impact Microsoft's financial outlook, as the tech giant has significant investments in OpenAI. The revised revenue figures could influence market perceptions and stock performance for Microsoft. https://openbell.ai/news/PCRX:1791478195354 2026-10-08T16:49:55.354Z daily 0.9 https://cdn.brandfetch.io/PCRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Viatris Bets Big on Non-Opioid Painkillers With Pacira Buyout Viatris Inc. has announced its acquisition of Pacira BioSciences Inc. for $1.65 billion, paying $36.50 per share in cash. This deal aims to enhance Viatris' non-opioid pain management portfolio, adding two established treatments: EXPAREL and ZILRETTA. Following the announcement, Viatris' stock fell nearly 3%, while Pacira's stock surged over 44%. The acquisition is expected to close by the end of 2026 and is anticipated to positively impact Viatris' financial metrics and operational synergies. https://openbell.ai/news/GKOS:1791478177248 2026-10-08T16:49:37.248Z daily 0.9 https://cdn.brandfetch.io/GKOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Glaukos Advances Eye Care Portfolio with Three-Year Epioxa Trial Data and Licensing Deal Glaukos Corporation (NYSE: GKOS) reported positive three-year trial results for its Epioxa treatment for keratoconus, demonstrating a 1.9 diopter improvement in maximum corneal curvature and maintaining a clean safety profile. Additionally, the company secured an exclusive licensing agreement with RevOpsis Therapeutics Inc. to develop RO-104, a biologic targeting multiple retinal conditions, while also gaining rights to develop up to four more retinal biologics. Following these announcements, Glaukos shares fell 10.76% to $153.65. https://openbell.ai/news/BIAF:1791478169878 2026-10-08T16:49:29.878Z daily 0.9 https://cdn.brandfetch.io/BIAF/w/400/h/400?c=1idopYfmtR7ZKg8QMud BIAF stock has given up its prior gain. bioAffinity Technologies shares were trading higher after the company announced that the Japan Patent Office issued a Notice of Allowance indicating its intention to grant a patent for the method of predicting the likelihood of lung cancer powered by the CyPath Lung test for early-stage lung cancer. openbell Financial News https://openbell.ai/news/DVN:1791478087211 2026-10-08T16:48:07.211Z daily 0.9 https://cdn.brandfetch.io/DVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Devon Energy Eagle Ford Sale to Boost Buybacks and Reduce Debt Devon Energy Corporation (NYSE: DVN) announced a deal to sell its Eagle Ford assets to Crescent Energy for $4.2 billion in cash, which represents about 4% of its total production. The sale is expected to enhance free cash flow, extend inventory life, and reduce debt, with proceeds allocated for share repurchases. The transaction is set to close around the end of 2026, pending regulatory approvals. Devon's shares rose by 2.07% to $48.87 following the announcement. https://openbell.ai/news/MSFT:1791477903141 2026-10-08T16:45:03.141Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'OpenAI annualised revenues $20bn less than previously signalled' - Financial Times OpenAI's annualized revenues are now reported to be $20 billion less than previously indicated. This adjustment could impact Microsoft's financial outlook, as the tech giant has significant investments in OpenAI. The revised revenue figures may lead to changes in market expectations regarding the performance of both companies. https://openbell.ai/news/XOM:1791477864503 2026-10-08T16:44:24.503Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Channahon--Illinois--Usa--June-7-2022-Ex.jpg?width=250&height=187 What's Going On With ExxonMobil Stock On Thursday? ExxonMobil (NYSE: XOM) shares rose approximately 2% on Thursday, trading at $167.89, following the Trump administration's proposed rollback of methane regulations, which could save oil and gas producers, including ExxonMobil, an estimated $45 billion annually in compliance costs. The global crude benchmarks also increased by over 4% amid ongoing Middle East tensions. Looking ahead, ExxonMobil's earnings report is expected on October 30, 2026, with an estimated EPS of $3.75 and revenue of $102.02 billion, reflecting significant year-over-year growth. https://openbell.ai/news/GFS:1791477817555 2026-10-08T16:43:37.555Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Konskie--Poland---January-22--2024-Globa.jpg?width=250&height=187 GlobalFoundries Lands $2 Billion TSMC Deal to Expand US AI Chip Packaging GlobalFoundries Inc. (NASDAQ: GFS) has entered a $2 billion, five-year manufacturing agreement with Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) to supply U.S.-produced silicon interposers for TSMC's advanced packaging ecosystem. The expansion at GlobalFoundries' Malta, New York facility aims to support high-performance computing and AI workloads, with volume production expected to start in the first half of 2028. Following the announcement, GFS shares rose 4.46% to $50.22. https://openbell.ai/news/WSM:1791477355587 2026-10-08T16:35:55.587Z daily 0.9 https://cdn.brandfetch.io/WSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Josh Brown Hosts Segment Titled "Josh's Best Stocks In The Market: Williams-Sonoma" openbell Financial News https://openbell.ai/news/IVN:1791477326456 2026-10-08T16:35:26.456Z daily 0.9 https://cdn.brandfetch.io/IVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Ivanhoe Mines, Raises Price Target to C$16 UBS analyst Daniel Major has maintained a Buy rating on Ivanhoe Mines (TSX: IVN) and increased the price target from C$15 to C$16. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/FUTU:1791476955558 2026-10-08T16:29:15.558Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Los-Angeles--California---July-11-2025-W.jpg?width=250&height=187 Webull Just Exposed a Bigger China Risk for Futu and UP Fintech Webull Corp (NASDAQ: BULL) is under congressional scrutiny for its ties to China, which could impact other companies like Futu Holdings Limited (NASDAQ: FUTU) and UP Fintech Holding Limited (NASDAQ: TIGR). Futu is facing a separate regulatory issue in China with a proposed penalty of approximately $271 million, while UP Fintech has also been penalized for unlicensed operations. Futu reported a 33.6% year-over-year increase in funded accounts and a 35.6% rise in revenue to HK$7.2 billion in Q2, indicating growth driven by international markets. https://openbell.ai/news/HBM:1791476927989 2026-10-08T16:28:47.989Z daily 0.9 https://cdn.brandfetch.io/HBM/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Hudbay Minerals, Raises Price Target to C$46 UBS analyst George Eadie has maintained a 'Buy' rating on Hudbay Minerals (TSX: HBM) and increased the price target from C$43 to C$46. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/BMY:1791476866211 2026-10-08T16:27:46.211Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Rueil-malmaison--France---August-13--202.jpg?width=250&height=187 Bristol Myers Squibb’s Zenbexus Delivers Major Blood Cancer Win, Cuts Progression Risk 51% Bristol Myers Squibb announced positive topline results from its Phase 3 EXCALIBER-RRMM study, showing that its drug Zenbexus (iberdomide) reduced the risk of disease progression or death by 51% in multiple myeloma patients. The study involved 800 individuals and demonstrated a median progression-free survival of 42 months for those treated with Zenbexus, compared to 20 months for the standard treatment. Following these results, Bristol Myers Squibb's stock was down 1.41% to $58.86. https://openbell.ai/news/FM:1791476486637 2026-10-08T16:21:26.637Z daily 0.9 https://cdn.brandfetch.io/FM/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on First Quantum Minerals, Raises Price Target to C$60 UBS has maintained a 'Buy' rating on First Quantum Minerals (TSX: FM) and increased its price target from C$55 to C$60. This adjustment reflects UBS's positive outlook on the company's performance. https://openbell.ai/news/AAPL:1791476025763 2026-10-08T16:13:45.763Z daily 0.9 https://cdn.brandfetch.io/AAPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bloomberg's Mark Gurman Posts On X "t's official: Apple has sent out invitations for a "Welcome home" product launch on Oct. 13 in New York." Apple has officially sent out invitations for a product launch event titled 'Welcome home' scheduled for October 13 in New York. This announcement was made by Bloomberg's Mark Gurman on X. The event may have implications for AAPL stock as new product launches often influence market performance. https://openbell.ai/news/BHVN:1791475911721 2026-10-08T16:11:51.721Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Richmond--Virginia--Usa---9-May-2019-Ill.jpg?width=250&height=187 Biohaven Expands Asian Licensing Footprint Through Strategic Ono Agreement Biohaven Ltd. (NYSE: BHVN) has entered a licensing agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize its MoDE pan IgG degrader portfolio in Japan, South Korea, Taiwan, and ASEAN countries. The agreement includes an upfront payment of $80 million and potential milestone payments totaling up to $100 million, along with approximately 20% royalties on net sales from licensed products. Biohaven's lead candidate, BHV-1300, is currently in Phase 3 clinical development for Graves' disease. https://openbell.ai/news/BIAF:1791475836762 2026-10-08T16:10:36.762Z daily 0.9 https://cdn.brandfetch.io/BIAF/w/400/h/400?c=1idopYfmtR7ZKg8QMud bioAffinity Technologies Commences ~$4M Offering Of Common Stock At $6.122 Per Share bioAffinity Technologies, Inc. has announced a registered direct offering of common stock, aiming to raise approximately $4 million at a price of $6.122 per share. The proceeds will be used for working capital and to support the expected growth in sales of its noninvasive lung cancer test, CyPath® Lung. The offering is conducted under Nasdaq rules and involves an institutional investor. https://openbell.ai/news/AXTA:1791475735437 2026-10-08T16:08:55.437Z daily 0.9 https://cdn.brandfetch.io/AXTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Conditional EU antitrust approval expected for AkzoNobel, Axalta deal, sources say' - Reuters The European Union is expected to grant conditional antitrust approval for the merger between AkzoNobel and Axalta, according to sources. This approval is a significant step forward for the deal, which aims to enhance AkzoNobel's position in the coatings market. The news may impact Axalta's stock performance, which is currently traded under the ticker AXTA. https://openbell.ai/news/ZBAO:1791475655290 2026-10-08T16:07:35.290Z daily 0.9 https://cdn.brandfetch.io/ZBAO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zhibao Technology shares are trading lower after the company announced a 1-for-50 reverse stock split. openbell Financial News https://openbell.ai/news/CS:1791475644491 2026-10-08T16:07:24.491Z daily 0.9 https://cdn.brandfetch.io/CS/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Capstone Copper, Raises Price Target to C$18 UBS analyst George Eadie has maintained a Buy rating on Capstone Copper (TSX: CS) and increased the price target from C$17 to C$18. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/BIAF:1791475373951 2026-10-08T16:02:53.951Z daily 0.9 https://cdn.brandfetch.io/BIAF/w/400/h/400?c=1idopYfmtR7ZKg8QMud bioAffinity Technologies shares are trading higher after the company announced that the Japan Patent Office issued a Notice of Allowance indicating its intention to grant a patent for the method of predicting the likelihood of lung cancer powered by the CyPath Lung test for early-stage lung cancer. openbell Financial News https://openbell.ai/news/CVX:1791475319369 2026-10-08T16:01:59.369Z daily 0.9 https://cdn.brandfetch.io/CVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Chevron, Raises Price Target to $235 UBS analyst Josh Silverstein has reaffirmed a Buy rating on Chevron (NYSE: CVX) and increased the price target from $220 to $235. https://openbell.ai/news/DKI:1791475189661 2026-10-08T15:59:49.661Z daily 0.9 https://cdn.brandfetch.io/DKI/w/400/h/400?c=1idopYfmtR7ZKg8QMud DarkIris shares are trading lower after the company announced the pricing of its $6 million offering of 4,166,666 units. openbell Financial News https://openbell.ai/news/ASTS:1791475180843 2026-10-08T15:59:40.843Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Istanbul--Turkey---5-Sep-2024-Ast-Spacem.jpg?width=250&height=187 Why Is AST SpaceMobile Stock Falling Thursday? AST SpaceMobile, Inc. (NASDAQ: ASTS) saw its stock decline nearly 7% on Thursday, closing at $56.64, amid broader market weakness and concerns regarding rising debt in the space industry, particularly following SpaceX's announcement of a $40 billion financing plan. The Nasdaq and S&P 500 also experienced declines of 0.57% and 0.34%, respectively. Technical indicators suggest continued weakness for ASTS, trading below its major moving averages, with key resistance at $65.50 and support around $55.50. https://openbell.ai/news/NEOG:1791474967575 2026-10-08T15:56:07.575Z daily 0.9 https://cdn.brandfetch.io/NEOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Neogen Stock Gaining Thursday? Neogen Corporation's stock rose 1.71% to $11.88 following the company's announcement of its fiscal 2031 growth and profitability targets during its 2026 Investor Day. Neogen aims for high-single-digit to low-double-digit revenue growth, a 30% adjusted EBITDA margin, and plans to reduce net leverage to below 2.5x. The company reported an 8.1% increase in core revenue for its recent fiscal first quarter, with adjusted EBITDA reaching $41.6 million, surpassing expectations. Neogen also plans to increase R&D spending by 50% by fiscal 2027, targeting new product innovations to contribute $100 million in incremental revenue by fiscal 2031. https://openbell.ai/news/TRGP:1791474695070 2026-10-08T15:51:35.070Z daily 0.9 https://cdn.brandfetch.io/TRGP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Targa Resources, Raises Price Target to $294 Barclays analyst Theresa Chen has maintained an Overweight rating on Targa Resources (NYSE: TRGP) and raised the price target from $284 to $294. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/SXTC:1791474656630 2026-10-08T15:50:56.630Z daily 0.9 https://cdn.brandfetch.io/SXTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud China SXT Pharmaceuticals shares are trading lower after the company announced a $12 million offering of 8 million shares at $1.50 per share. openbell Financial News https://openbell.ai/news/JZ:1791474627218 2026-10-08T15:50:27.218Z daily 0.9 https://cdn.brandfetch.io/JZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jianzhi Education Technology Group shares are trading higher after the company announced a buyback plan. openbell Financial News https://openbell.ai/news/USO:1791474618171 2026-10-08T15:50:18.171Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Houthis Say It Struck King Khalid Airport In Riyadh With Two Cruise Missiles; Najran Airport With A Ballistic Missile; Khamis Mushait Airbase With A Ballistic Missile The Houthis have claimed responsibility for launching two cruise missiles at King Khalid Airport in Riyadh and a ballistic missile at Najran Airport, as well as another ballistic missile at Khamis Mushait Airbase. This escalation in military action could have implications for regional stability and may impact oil prices, particularly affecting companies in the energy sector such as USO. https://openbell.ai/news/SHLS:1791474562655 2026-10-08T15:49:22.655Z daily 0.9 https://cdn.brandfetch.io/SHLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Shoals Technologies Group, Raises Price Target to $11 Barclays analyst Christine Cho has maintained an Overweight rating on Shoals Technologies Group (NASDAQ: SHLS) and raised the price target from $10 to $11. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/CMG:1791474486980 2026-10-08T15:48:06.980Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: Chipotle Stock Eyes Best Day Since July on Starbucks' Takeover Interest Chipotle Mexican Grill Inc. (NYSE: CMG) saw its stock rise 7% to $32.94, marking its best performance since July 30. This increase follows reports that Starbucks Corp. (NASDAQ: SBUX) is considering a takeover, with Starbucks CEO Brian Niccol, who previously led Chipotle, potentially reuniting with the chain. Despite the recent stock surge, Chipotle's shares are down 11.8% year-to-date and have lost about 50% of their value since June 2024, with a current market capitalization of $41 billion. https://openbell.ai/news/SPCX:1791474455069 2026-10-08T15:47:35.069Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Elon-Musk--founder--CEO--and-chief-engin.jpg?width=250&height=187 SpaceX’s $500 Billion AI Data Center Gamble Has Real Revenue Behind It, Says FT’s John Foley SpaceX is planning a significant investment of up to $500 billion to expand its AI data centers from 1.4 gigawatts to nearly 10 gigawatts by the end of 2027. The company currently has contracts with Anthropic and Google's parent company, Alphabet, worth approximately $26 billion annually. SpaceX is also seeking an additional $40 billion to purchase Nvidia chips for these data centers. Despite having around $90 billion in cash, concerns exist regarding rental price stability and customer retention as competition increases. https://openbell.ai/news/RGA:1791474423463 2026-10-08T15:47:03.463Z daily 0.9 https://cdn.brandfetch.io/RGA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Reinsurance Group, Raises Price Target to $292 Barclays analyst Alex Scott has maintained an Overweight rating on Reinsurance Group (NYSE:RGA) and increased the price target from $286 to $292. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/NEOG:1791474107844 2026-10-08T15:41:47.844Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Munich--Bavaria--Germany---March-31-2023.jpg?width=250&height=187 Why Is Neogen Stock Gaining Thursday? Neogen Corporation's stock rose 1.71% to $11.88 after the company presented its fiscal 2031 growth and profitability targets at its 2026 Investor Day. The company aims for high-single-digit to low-double-digit revenue growth, a 30% adjusted EBITDA margin, and plans to increase R&D spending by 50% by fiscal 2027. Neogen also reported a stronger fiscal first quarter with an 8.1% rise in core revenue and adjusted EBITDA of $41.6 million, exceeding expectations. https://openbell.ai/news/TSLA:1791473859553 2026-10-08T15:37:39.553Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Oct. 7: Slovakia Transport Minister Jozef Raz Announces Tesla Full Self-Driving Will Soon Be Available In Country Slovakia's Transport Minister Jozef Raz announced on October 7 that Tesla's Full Self-Driving technology will soon be available in the country. This development is expected to enhance Tesla's presence in the European market. Further details regarding the rollout timeline or specific features were not disclosed. https://openbell.ai/news/TREX:1791473763998 2026-10-08T15:36:03.998Z daily 0.9 https://cdn.brandfetch.io/TREX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Upgrades Trex Co to Buy, Raises Price Target to $57 Deutsche Bank analyst Collin Verron has upgraded Trex Co (NYSE: TREX) from a 'Hold' rating to 'Buy.' The price target for Trex has been raised from $53 to $57. https://openbell.ai/news/MI:1791473672277 2026-10-08T15:34:32.277Z daily 0.9 https://cdn.brandfetch.io/MI/w/400/h/400?c=1idopYfmtR7ZKg8QMud NFT Limited Shares Resume Trade; Shares Then Halted On Circuit Breaker To The Downside, Stock Now Down -40.26% openbell Financial News https://openbell.ai/news/SPY:1791473657857 2026-10-08T15:34:17.857Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud U.S. Department Of War Announces $350M In Quantum Computing Initiatives The U.S. Department of War has announced a $350 million investment in quantum computing initiatives aimed at advancing technological capabilities. This funding is part of a broader strategy to enhance national security through innovative computing solutions. The announcement may impact the defense and technology sectors, potentially influencing stock prices, including that of SPY. https://openbell.ai/news/VMET:1791473343445 2026-10-08T15:29:03.445Z daily 0.9 https://cdn.brandfetch.io/VMET/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Initiates Coverage On Versamet Royalties with Buy Rating, Announces Price Target of C$21 TD Cowen analyst Derick Ma has initiated coverage on Versamet Royalties (TSX: VMET) with a Buy rating. The firm has set a price target of C$21 for the stock. https://openbell.ai/news/LW:1791473337889 2026-10-08T15:28:57.889Z daily 0.9 https://cdn.brandfetch.io/LW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Lamb Weston Holdings, Raises Price Target to $58 Barclays analyst Andrew Lazar has maintained an Overweight rating on Lamb Weston Holdings (NYSE: LW) and raised the price target from $56 to $58. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/BULL:1791473261192 2026-10-08T15:27:41.192Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Los-Angeles--California---July-7-2025-We.jpg?width=250&height=187 Webull Stock Trends: What's Going On? Webull Corp (NASDAQ: BULL) shares are experiencing a decline, trading at $5.805, down 1.36%, following a congressional report that identified the brokerage's ties to China as a national security risk. The House Select Committee on China revealed that Webull's operations are closely linked to the People's Republic of China, with significant concerns about data security and the management of $24.6 billion in customer assets. Additionally, Webull's stock is trading significantly below its key moving averages, indicating potential selling pressure. https://openbell.ai/news/EDIT:1791473159652 2026-10-08T15:25:59.652Z daily 0.9 https://cdn.brandfetch.io/EDIT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Upgrades Editas Medicine to Overweight, Raises Price Target to $6 Wells Fargo analyst Yanan Zhu has upgraded Editas Medicine (NASDAQ: EDIT) from Equal-Weight to Overweight. The price target for the stock has been raised from $4 to $6. https://openbell.ai/news/MI:1791473121770 2026-10-08T15:25:21.770Z daily 0.9 https://cdn.brandfetch.io/MI/w/400/h/400?c=1idopYfmtR7ZKg8QMud NFT Limited Shares Halted, News Pending openbell Financial News https://openbell.ai/news/IREN:1791472993968 2026-10-08T15:23:13.968Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Modern-Data-Center-With-Ai-Server-Racks-.jpg?width=250&height=187 Bitcoin Slide Meets 5.7% Bond Yields: Neoclouds Get Hit From Both Sides Neocloud companies, which transitioned from Bitcoin mining to AI data-center operations, are facing challenges due to a decline in Bitcoin prices and rising bond yields. Bitcoin is currently trading around $82,496, down approximately 35% from its 52-week high of $126,296. Stocks of companies like Cipher Digital, Riot Platforms, and CleanSpark have dropped significantly, with Cipher down 7.5% and 55.3% below its 52-week high. Additionally, the 30-year Treasury yield has risen to 5.705%, increasing borrowing costs for these firms. https://openbell.ai/news/JXN:1791472841455 2026-10-08T15:20:41.455Z daily 0.9 https://cdn.brandfetch.io/JXN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Jackson Financial, Raises Price Target to $151 Barclays analyst Alex Scott has maintained an Overweight rating on Jackson Financial (NYSE: JXN) and raised the price target from $150 to $151. This adjustment reflects a positive outlook for the company in the financial market. https://openbell.ai/news/U:1791472675662 2026-10-08T15:17:55.662Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/UnityShanghai-china-april-22nd-2023-Clos.jpg?width=250&height=187 Why Is Unity Software Stock Gaining Thursday? Unity Software Inc. (NYSE: U) saw its stock rise approximately 2% on Thursday following an upgrade from Raymond James, which moved the stock rating from Market Perform to Outperform with a price target of $54. The upgrade was attributed to Unity's recent partnership with Alphabet Inc.'s Google, which is expected to enhance Unity's development capabilities. Despite a broader market decline, Unity's stock performance remained strong, trading at $46.35 at the time of publication. https://openbell.ai/news/MU:1791472610779 2026-10-08T15:16:50.779Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Memory Chip Sales on Track to Top $2 Trillion By 2030: The Numbers Micron Bulls Need to Know Memory chip sales are projected to exceed $2 trillion by 2030, with Bank of America forecasting a significant growth trajectory for the sector. In the second quarter of 2026, memory chip sales surged 384% year-over-year, capturing 57% of global semiconductor sales. Micron Technology reported a fiscal fourth-quarter revenue of $54.23 billion, a substantial increase from $11.32 billion a year earlier. Despite a recent 2.2% decline in Micron's stock price, Bank of America maintains a price target of $1,550, indicating a potential 50% upside. https://openbell.ai/news/SITE:1791472390542 2026-10-08T15:13:10.542Z daily 0.9 https://cdn.brandfetch.io/SITE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Downgrades SiteOne Landscape Supply to Hold, Lowers Price Target to $91 Deutsche Bank analyst Collin Verron has downgraded SiteOne Landscape Supply (NYSE: SITE) from a Buy rating to Hold. The price target for the stock has been reduced from $127 to $91. https://openbell.ai/news/CHYM:1791472204735 2026-10-08T15:10:04.735Z daily 0.9 https://cdn.brandfetch.io/CHYM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Upgrades Chime Financial to Buy, Raises Price Target to $35 Deutsche Bank analyst Nate Svensson has upgraded Chime Financial (NASDAQ: CHYM) from Hold to Buy. The price target for the stock has been raised from $30 to $35. https://openbell.ai/news/LMT:1791472090761 2026-10-08T15:08:10.761Z daily 0.9 https://cdn.brandfetch.io/LMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lockheed Martin To Deliver S-70 BLACK HAWK Helicopter Training Devices And Services To The Philippine Air Force Lockheed Martin has announced a contract to deliver S-70 BLACK HAWK helicopter training devices and services to the Philippine Air Force. This deal is part of Lockheed Martin's ongoing efforts to support military training and enhance operational capabilities in the region. The financial details of the contract have not been disclosed.